论文信息 - Successful treatment of two cases of refractory cutaneous lupus erythematosus with belimumab. - 字舞流文

Successful treatment of two cases of refractory cutaneous lupus erythematosus with belimumab.

G. Espinosa | P. Giavedoni | A. Combalia | D. Morgado-Carrasco | X. Bosch-Amate | J. Mascaró

[1] J. Wenzel,et al. High expression of B lymphocyte stimulator in lesional keratinocytes of patients with cutaneous lupus erythematosus , 2018, Experimental dermatology.

[2] J. Merola,et al. Characteristics and Alternative Treatment Outcomes of Antimalarial-Refractory Cutaneous Lupus Erythematosus , 2017, JAMA dermatology.

[3] J. O'dell,et al. Belimumab for the treatment of recalcitrant cutaneous lupus , 2017, Lupus.

[4] R. Fischer-Betz,et al. The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation , 2016, Annals of the rheumatic diseases.

[5] D. Gladman,et al. Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: combined results from two phase III trials , 2012, Annals of the rheumatic diseases.

[6] A. Dubey,et al. Belimumab: First targeted biological treatment for systemic lupus erythematosus , 2011, Journal of pharmacology & pharmacotherapeutics.